FDA Published Draft Guidance on Development of CAR-T Cell Products Post author:PacConAdmin Post published:March 15, 2022 Post category:Drug Industry Daily The FDA has posted draft guidance for sponsors developing CAR-T cell products. Source: Drug Industry Daily You Might Also Like Lawsuit Claims FDA Hurt Research Firm’s Reputation January 23, 2018 Senate Passes Bill That Would End Gag Clauses for Insurers, PBMs September 18, 2018 Democrats Try Again on Drug Importation February 28, 2017